Status:
COMPLETED
The Role of Circadian Rhythms in Cancer-Related Symptoms
Lead Sponsor:
Aarhus University Hospital
Collaborating Sponsors:
University of Aarhus
Danish Cancer Society
Conditions:
Breast Cancer
Fatigue
Eligibility:
FEMALE
18+ years
Brief Summary
Emerging evidence indicates that circadian rhythms may be disrupted following cancer and its treatment, and that circadian rhythm disruption may be an underlying pathophysiological mechanism of cancer...
Eligibility Criteria
Inclusion
- Patients with early breast cancer scheduled for surgery and chemotherapy (neoadjuvant or adjuvant) at Aarhus University Hospital (AUH).
- The healthy control group will consist of an age-matched sample of participants with no history of cancer.
Exclusion
- Pregnancy
- Shift-work
- Melatonin supplementation
- Insufficient Danish proficiency
- Previous cancer diagnosis except for treated non-melanoma skin cancer
- Confounding diagnosed or suspected psychiatric or medical conditions that might significantly contribute to the CRS or symptoms/diagnoses resembling them (other than those caused by cancer or its treatment) such as seasonal affective disorder.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT04401189
Start Date
June 1 2020
End Date
June 30 2023
Last Update
June 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Denmark, 8200